cell-mediated immunity ( cmi ) in prostatic cancer patients to presumptively identified prostatic tumour-associated antigens ( taa ) was further evaluated in this study by tube leukocyte adherence inhibition in 504 patients with and without prostatic cancer .
C0033572
prostatic
C0376358
prostatic cancer